1-4 of 4
Srikanth R. Ambati
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1625: Ureidomustine, a novel DNA-crosslinking agent shows activity in sarcoma preclinical models and lacks toxicity in normal tissues

Srikanth R. Ambati, Shieh JaeHung, Benet Pera, Elissa W.P. Wong, Eloisi Caldas Lopes, Elizabeth Peguero, Tsann-Long Su, Malcolm A.S. Moore
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1625.
DOI: https://doi.org/10.1158/1538-7445.AM2015-1625
Published: 01 August 2015
View article
Journal Articles

Abstract 3980: Pre-clinical evaluation of a novel DNA crosslinking agent, Ureidomustin (BO-1055) in pediatric sarcomas

Srikanth R. Ambati, Elissa W. Wong, Benet Pera, Elizabeth Peguero, Eloisi Caldas Lopes, Jin-Jer Chen, Jae-Hung Shieh, Tsann-Long Su, Malcolm A. Moore
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3980.
DOI: https://doi.org/10.1158/1538-7445.AM2014-3980
Published: 01 October 2014
View article
Journal Articles

Abstract 4021: Transcriptomic landscape of Ewing sarcoma based on RNAseq.

Ahmet Zehir, Srikanth R. Ambati, Malcolm AS Moore
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4021.
DOI: https://doi.org/10.1158/1538-7445.AM2013-4021
Published: 15 April 2013
View article
Journal Articles

Abstract 2752: Novel inhibitor of HSP90- PU-H71 exhibits significant activity in Ewing sarcoma pre-clinical models.

Srikanth R. Ambati, Eloisi Caldas Lopes, Ullas Mony, Kohji Kosugi, Andre Moreira, Paul Meyers, Gabriela Chiosis, Malcolm Moore
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2752.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2752
Published: 15 April 2013
View article